Hypera (STU:HM6A) Cyclically Adjusted Revenue per Share: € (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:HM6A Hypera SA STU:HM6A
96 GF Score
Price €3.74
GF Value €4.99
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Hypera Cyclically Adjusted Revenue per Share?

Hypera STU:HM6A -5.08% 96 Cyclically Adjusted Revenue per Share is € as of Jun. 2026. GuruFocus rates STU:HM6A with a GF Score™ of 96/100 and a GF Value™ of €4.99 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Hypera's adjusted revenue per share for the three months ended in Jun. 2026 was €0.565. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is for the trailing ten years ended in Jun. 2026.

During the past 12 months, Hypera's average Cyclically Adjusted Revenue Growth Rate was 10.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Hypera was 7.90% per year. The lowest was 0.50% per year. And the median was 6.25% per year.

As of today (2026-09-21), Hypera's current stock price is €3.74. Hypera's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was . Hypera's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Hypera was 6.05. The lowest was 1.85. And the median was 4.21.


Hypera  (STU:HM6A) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Hypera was 6.05. The lowest was 1.85. And the median was 4.21.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Hypera Cyclically Adjusted Revenue per Share Related Terms


Hypera Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Hypera's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypera Cyclically Adjusted Revenue per Share Chart

Hypera Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Hypera Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

STU:HM6A vs ZTS, UTHR, VTRS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hypera's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hypera Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hypera's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Hypera's Cyclically Adjusted PS Ratio falls into.


STU:HM6A
96GF Score
Hypera SA STU:HM6A
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hypera Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hypera's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.565/177.5443*177.5443
=0.565

Current CPI (Jun. 2026) = 177.5443.

Hypera Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.351 109.986 0.567
201612 0.373 110.802 0.598
201703 0.382 111.869 0.606
201706 0.365 112.115 0.578
201709 0.369 112.777 0.581
201712 0.423 114.068 0.658
201803 0.361 114.868 0.558
201806 0.332 117.038 0.504
201809 0.323 117.881 0.486
201812 0.325 118.340 0.488
201903 0.139 120.124 0.205
201906 0.341 120.977 0.500
201909 0.359 121.292 0.525
201912 0.297 123.436 0.427
202003 0.256 124.092 0.366
202006 0.275 123.557 0.395
202009 0.271 125.095 0.385
202012 0.267 129.012 0.367
202103 0.274 131.660 0.369
202106 0.365 133.871 0.484
202109 0.415 137.913 0.534
202112 0.382 141.992 0.478
202203 0.397 146.537 0.481
202206 0.559 149.784 0.663
202209 0.602 147.800 0.723
202212 0.602 150.207 0.712
202303 0.474 153.352 0.549
202306 0.641 154.519 0.737
202309 0.624 155.464 0.713
202312 0.538 157.148 0.608
202403 0.527 159.372 0.587
202406 0.606 161.052 0.668
202409 0.489 162.342 0.535
202412 0.371 164.740 0.400
202503 0.275 168.102 0.290
202506 0.521 169.670 0.545
202509 0.544 170.739 0.566
202512 0.554 171.765 0.573
202603 0.512 175.066 0.519
202606 0.565 177.544 0.565

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of € mean?
Hypera (STU:HM6A) has a Cyclically Adjusted Revenue per Share of € as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Hypera and its competitors.
Is Hypera's Cyclically Adjusted Revenue per Share too high?
Hypera's current Cyclically Adjusted Revenue per Share is €. Overall, Hypera has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hypera's Cyclically Adjusted Revenue per Share compare to ZTS and UTHR?
Hypera's Cyclically Adjusted Revenue per Share of € can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Hypera and its competitors. Hypera's current Cyclically Adjusted Revenue per Share is €. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypera stock overvalued right now?
Based on GuruFocus' analysis, Hypera (STU:HM6A) is currently considered Modestly Undervalued. The stock's GF Value™ is €4.99, compared to a current price of €3.74 — trading 25.1% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €. Hypera's overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Hypera (STU:HM6A), the current Cyclically Adjusted Revenue per Share is € as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hypera (STU:HM6A) Overvalued in 2026?

Based on GuruFocus' analysis, Hypera stock appears to be undervalued. The current stock price of €3.74 is trading 25.1% below its estimated GF Value™ of €4.99. GuruFocus considers Hypera to be Modestly Undervalued.

Key valuation signals for STU:HM6A:

  • Cyclically Adjusted Revenue per Share:
  • GF Value™: €4.99 vs. price of €3.74 (25.1% below fair value)
  • GF Score™: 96/100 with 4 warning signs

No single metric tells the full story. See the STU:HM6A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hypera Business Description

Other Exchanges HYPMY:USAHYPE3:Brazil
Address Avenida Magalhaes de Castro, 4800, 240 Floor Continental Tower Building, Bairro Cidade Jardim, Sao Paulo, SP, BRA, CEP 05676-120
Hypera SA is a specialty and generic drug manufacturing company. The company operates in the prescription medicines, over-the-counter (OTC) medicines, branded generics, and generics, and skincare segments within the retail pharmaceutical market. The company also has a wide sales and distribution structure. The company's product portfolio includes key brands in Gastroenterology, Pain, Sun Protection, Skin Moisture, and Cleansing within the over-the-counter (OTC) and Skincare segments, as well as new products in Cardiology, Central Nervous System, and Respiratory System within the prescription medicines segment.
96GF Score

Get the complete analysis for STU:HM6A

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.74
Price
€4.99
GF Value